国家医保局：“十四五”时期累计将949种药品新增纳入医保目录

Core Insights - The National Medical Insurance Administration held a meeting on December 13, focusing on optimizing the medical insurance payment mechanism during the 14th Five-Year Plan period to promote the development of healthcare and the pharmaceutical industry [1] Group 1: Medical Insurance Policy Changes - A total of 949 new drugs have been added to the medical insurance catalog, bringing the total number of drugs in the catalog to 3,253 [1] - The issuance of measures to support the high-quality development of innovative drugs includes the establishment of a commercial health insurance catalog for innovative drugs, which includes 19 drugs with significant clinical value and high innovation levels [1] Group 2: Payment Mechanism Enhancements - The implementation of disease-based payment has started from pilot programs and is now set for comprehensive coverage, with the introduction of version 2.0 of the disease-based payment scheme [1] - Five supporting mechanisms, including special case negotiations, have been established to alleviate concerns for medical institutions regarding the treatment of critically ill patients and the use of new drugs and technologies [1] Group 3: Financial Relief for Medical Institutions - All coordinated regions across the country will implement immediate settlement, effectively relieving the financial pressure on medical institutions regarding upfront costs [1]